StockData
Arrowhead Pharmaceuticals, Inc. logo

Arrowhead Pharmaceuticals, Inc. (ARWR) stock

ARWRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-K on Nov 12, 2026Score 5/3035% above fair value
$43.11+0.12 (+0.28%)

Close on Nov 18, 2026Market cap $6.09BP/E –Yield –

Arrowhead Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Arrowhead Pharmaceuticals's price to book ratio was 15.0× on Nov 11, 2026, against 15.3× a year earlier. Over the last 5 years it ranged from 3.2× to 45.2×, with a median of 12.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202615.0×−4.4
2025Dec 31, 202519.3×+6.7
2024Dec 31, 202412.6×+0.5
2023Dec 29, 202312.1×+1.3
2022Dec 30, 202210.8×−6.1
2021Dec 31, 202116.9×−0.1
2020Dec 31, 202017.0×−7.8
2019Dec 31, 201924.8×+13.3
2018Dec 31, 201811.5×+8.1
2017Dec 29, 20173.4×+2.2
2016Dec 30, 20161.1×−2.2
2015Dec 31, 20153.3×+0.9
2014Dec 31, 20142.4×−10.4
2013Dec 31, 201312.8×+9.9
2012Dec 31, 20122.9×+0.1
2011Dec 30, 20112.8×−4.3
2010Dec 31, 20107.1×–

More Arrowhead Pharmaceuticals figures

See a number that looks wrong?